By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Juniper Pharma (Formerly known as Columbia Laboratories) 

4 Liberty Square

Boston  Massachusetts  02109  U.S.A.
Phone: 617-639-1500 Fax: n/a



Company News
Juniper Pharma (JNP) Reports Third Quarter 2016 Financial Results 11/15/2016 10:20:15 AM
Juniper Pharma (JNP) To Report Third Quarter 2016 Results On November 15, 2016 11/15/2016 8:50:20 AM
Juniper Pharma (JNP) Monetizes U.S. Crinone Royalty Stream With Allergan (AGN) 11/15/2016 7:27:37 AM
Juniper Pharma (JNP) To Present At Rodman & Renshaw Global Investment Conference On September 12, 2016 9/1/2016 11:56:11 AM
Boston's Juniper Pharma (JNP) Terminates Development of Lidocaine Bioadhesive Gel After Phase II Trial Failure 8/18/2016 5:36:32 AM
Juniper Pharma (JNP) Reports Second Quarter 2016 Financial Results 8/4/2016 8:27:56 AM
Juniper Pharma (JNP) To Report Second Quarter 2016 Results On August 4, 2016 7/26/2016 6:57:30 AM
Zafgen (ZFGN)'s Alicia Secor Steps Up as Juniper Pharma (JNP)’s President and CEO 7/20/2016 5:42:21 AM
Juniper Pharma (JNP) Announces Completion Of Enrollment In Phase 2b Clinical Trial Of COL-1077 10% Lidocaine Vaginal Gel For Gynecologic Procedure Pain 7/7/2016 7:22:52 AM
Juniper Pharma (JNP) Announces That Merck KGaA (MKGAF.PK), Darmstadt, Germany, Has Obtained Regulatory Approval For OneCrinone In Japan 7/5/2016 6:19:17 AM